KOBIO KoAct US BioHealthcare Active ETF Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Sources
YouTube
Twitter
Reddit
Substack
Insider
Loading...
0 selected
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
02:20
Jul 02
Active ETF to ride biotech M&A wave
KoAct US BioHealthcare Active ETF is an active strategy designed to capture event-driven M&A momentum in biotech. With M&A volumes approaching 2018 highs and big pharma needing to replenish pipelines ahead of the patent cliff, an active manager can rotate into targets and catalyst events, offering a more dynamic exposure than a passive index.
KOBIO 1ST
MED

About KOBIO Analyst Coverage

Buzzberg tracks KOBIO (KoAct US BioHealthcare Active ETF) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked. Latest voices: Park Hyun-ji.